| 25/429 |
Lead for Regional Anaesthesia |
| 25/428 |
Drug Treatments - Biologics (Gastro) |
| 25/427 |
Logistics and Supply |
| 25/426 |
Staff Policy Regarding use of Fragranced Products |
| 25/425 |
HSCN (Health and Social Care Network) and Connectivity |
| 25/424 |
Contact Details |
| 25/423 |
Sexual Assault Referral Centre (SARC) |
| 25/422 |
Formaldehyde Exposure Control and Compliance |
| 25/421 |
Trusts Integration Engine |
| 25/420 |
Off Framework Agencies |
| 25/419 |
Contracts for Firewall, Anti-virus, Microsoft Enterprise Agreement, and Power BI |
| 25/418 |
Oncology Breast Cancer |
| 25/417 |
Consultant Posts |
| 25/416 |
Translation and Interpretation Costs |
| 25/415 |
Dravet syndrome and Lennox-Gastaut syndrome |
| 25/414 |
Cyber Security Incidents and Measures (FY22–FY25) |
| 25/413 |
Pancreatic Enzyme Replacement Therapy (PERT) |
| 25/412 |
Internet Connections |
| 25/411 |
Cellular Pathology Services [Histology] |
| 25/410 |
Agency Spend April 2025 |
